Envestnet Asset Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $257K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $39.6K | Sell |
|
|||||
|
2023
Q3 | $82.8K | Buy |
|
|||||
|
2023
Q2 | $69.6K | Sell |
|
|||||
|
2023
Q1 | $117K | Buy |
|
|||||
|
2022
Q4 | $127K | Sell |
|
|||||
|
2022
Q3 | $232K | Buy |
|
|||||
|
2022
Q2 | $129K | Sell |
|
|||||
|
2022
Q1 | $245K | Sell |
|
|||||
|
2021
Q4 | $418K | Buy |
|
|||||
|
2021
Q3 | $370K | Buy |
|
|||||
|
2021
Q2 | $286K | Buy |
|
|||||
|
2021
Q1 | $299K | Sell |
|
|||||
|
2020
Q4 | $358K | Buy |
|
|||||
|
2020
Q3 | $252K | Sell |
|
|||||
|
2020
Q2 | $254K | Sell |
|
|||||
|
2020
Q1 | $811K | Buy |
|
|||||
|
2019
Q4 | $813K | Buy |
|
|||||
|
2019
Q3 | $865K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $18K | Buy |
|
|||||
|
2018
Q1 | $12K | Buy |
|
|||||
|
2017
Q4 | $5K | Buy |
|